On this page you will find our recommendations sorted by BNF chapter.
Appraisal Reports are available to stakeholders on request.
Where a decision is >24 months old; these are highlighted in red. If you are a clinician working within the NTAG region and would like to prioritise an old decision for re-review please contact the professional secretary on email@example.com
|Airsonett® laminar flow device for treatment of uncontrolled allergic asthma||Recommendation||Not recommended||01/09/2020|
|Dupilumab and Omalizumab for chronic rhinosinusitis with nasal polyps||Recommendation||Not recommended for use ahead of NICE TA||08/06/2021|